Guggenheim Capital’s Enovis ENOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$306K Sell
14,771
-382
-3% -$9.01K ﹤0.01% 1502
2026
Q1
$345K Buy
15,153
+2,520
+20% +$59.6K ﹤0.01% 1331
2025
Q4
$337K Buy
12,633
+3,810
+43% +$113K ﹤0.01% 1473
2025
Q3
$268K Buy
+8,823
New +$268K ﹤0.01% 1423
2024
Q4
Sell
-182,232
Closed -$7.85M 1750
2024
Q3
$7.85M Sell
182,232
-4,210
-2% -$188K 0.05% 392
2024
Q2
$8.43M Sell
186,442
-67
-0% -$3.48K 0.06% 352
2024
Q1
$11.6M Buy
186,509
+358
+0.2% +$21.4K 0.08% 276
2023
Q4
$10.4M Buy
186,151
+72,101
+63% +$3.59M 0.08% 299
2023
Q3
$6.01M Sell
114,050
-1,851
-2% -$108K 0.05% 436
2023
Q2
$7.43M Buy
115,901
+1,529
+1% +$87.1K 0.06% 392
2023
Q1
$6.12M Sell
114,372
-2,368
-2% -$137K 0.05% 450
2022
Q4
$6.25M Buy
116,740
+7,459
+7% +$385K 0.05% 439
2022
Q3
$5.04M Buy
109,281
+1
+0% +$54 0.05% 501
2022
Q2
$6.01M Sell
109,280
-15,841
-13% -$1.02M 0.05% 465
2022
Q1
$8.57M Buy
125,121
+31,274
+33% +$2.23M 0.05% 444
2021
Q4
$7.42M Sell
93,847
-4,380
-4% -$366K 0.04% 524
2021
Q3
$7.76M Sell
98,227
-3,786
-4% -$304K 0.05% 482
2021
Q2
$8.04M Sell
102,013
-2,386
-2% -$183K 0.05% 472
2021
Q1
$7.87M Buy
104,399
+19,905
+24% +$1.46M 0.05% 445
2020
Q4
$5.56M Buy
84,494
+5,759
+7% +$337K 0.03% 536
2020
Q3
$4.25M Buy
78,735
+19,978
+34% +$1.1M 0.03% 592
2020
Q2
$2.82M Buy
+58,757
New +$2.59M 0.02% 734
2019
Q3
Sell
-7,601
Closed -$367K 2099
2019
Q2
$367K Buy
7,601
+890
+13% +$42.8K ﹤0.01% 1792
2019
Q1
$342K Buy
+6,711
New +$294K ﹤0.01% 1849
2018
Q4
Sell
-8,872
Closed -$551K 2220
2018
Q3
$551K Sell
8,872
-1,331
-13% -$75.8K ﹤0.01% 1922
2018
Q2
$538K Sell
10,203
-20,685
-67% -$1.12M ﹤0.01% 1911
2018
Q1
$1.7M Buy
30,888
+1,868
+6% +$115K ﹤0.01% 1765
2017
Q4
$1.98M Buy
29,020
+2,099
+8% +$141K ﹤0.01% 1675
2017
Q3
$1.93M Buy
26,921
+557
+2% +$38.8K ﹤0.01% 1695
2017
Q2
$1.79M Buy
26,364
+19,389
+278% +$1.32M ﹤0.01% 1709
2017
Q1
$471K Buy
+6,975
New +$465K ﹤0.01% 2401
2016
Q2
Sell
-132,562
Closed -$6.52M 2892
2016
Q1
$6.52M Buy
+132,562
New +$5.64M 0.02% 873
2015
Q3
Sell
-3,007
Closed -$239K 2976
2015
Q2
$239K Buy
3,007
+311
+12% +$26.3K ﹤0.01% 2772
2015
Q1
$222K Sell
2,696
-4,479
-62% -$375K ﹤0.01% 2772
2014
Q4
$637K Sell
7,175
-207,719
-97% -$18.8M ﹤0.01% 2427
2014
Q3
$21.1M Buy
214,894
+70,169
+48% +$7.88M 0.05% 627
2014
Q2
$18.6M Buy
144,725
+140,077
+3,014% +$17.5M 0.05% 692
2014
Q1
$570K Sell
4,648
-802
-15% -$92.1K ﹤0.01% 2538
2013
Q4
$597K Buy
+5,450
New +$546K ﹤0.01% 2479

Other funds holding ENOV

Guggenheim Capital's ENOV Position: Q2 2026 in Review

Guggenheim Capital reduced its Enovis (ENOV) stake by 2.5% in Q2 2026, selling an estimated $9.01K and leaving 14,771 shares worth $306K. The position accounts for ﹤0.01% of the portfolio, ranked #1502.

Guggenheim Capital first reported a position in ENOV in Q4 2013 and has held it in 39 quarters since. The position peaked at $21.1M in Q3 2014. 251 funds tracked by Wall St. Rank hold ENOV as of Q2 2026.

  • Guggenheim Capital held 14,771 shares of Enovis worth $306K as of Q2 2026.
  • Guggenheim Capital sold 382 Enovis shares in Q2 2026, an estimated $9.01K.
  • Enovis made up ﹤0.01% of Guggenheim Capital's portfolio in Q2 2026, its #1502 holding.
  • Guggenheim Capital first reported a position in Enovis in Q4 2013 and has held it in 39 quarters since.
  • Guggenheim Capital's Enovis position peaked at $21.1M in Q3 2014.
  • 251 funds tracked by Wall St. Rank held Enovis as of Q2 2026.

Based on Guggenheim Capital's 13F filing for Q2 2026, filed 12 Aug 2026.